O=C(CSc1nnc(-c2ccc(/N=C\c3ccc(Cl)cc3)cc2)o1)Nc1ccccc1[N+](=O)[O-]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?